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Abstract 
Background: Patient assistance programs, including medication management and counseling, have the potential to improve care in 
chronic disease states with complex therapies. Incorporating technology as a tool to foster adherence is becoming more commonplace 
in practice. 
Objectives:  The purpose of this report is to identify barriers of medication adherence and review the impact of patient assistance 
programs and technology on medication adherence. 
Methods: A literature search was conducted in secondary databases, PubMed/MEDLINE and EBSCOhost of peer-reviewed systematic 
reviews, experimental, quasi-experimental, and observational reports published in English within the last fifteen years. Terms searched 
included patient assistance program, pharmacist role, technology, adherence or compliance, income and health. 
Results: Ten studies met our prespecified criteria. Male sex, several self-reported chronic diseases, negative expectancy of treatment, 
engagement in polypharmacy, financial hardships and lower education level correlated with lower medication adherence. Patient care 
assistance programs and utilization of technology (e.g., use of a mobile application) improved medication adherence. 
Conclusions: Patient assistance programs and technological tools, such as mobile applications, are necessary resources in improving 
medication adherence.  
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Background 
Patient assistance programs, including medication 
management and counseling, have the potential to improve 
care in chronic disease states with complex therapies.1 Financial 
and other socioeconomic burdens (i.e., education level) while 
suffering from multiple comorbid conditions can hinder 
patients from taking their medications as prescribed leading to 
further complications.  In one study patients were asked why 
their conditions were not controlled, and the main reason 
reported was being unable to afford medications due to high 
co-pays and other medication-related costs.2 Another common 
answer was patients did not correctly understand the 
treatment or diagnosed condition and were too embarrassed 
to ask a physician further questions.2 Cultural differences and 
beliefs may affect adherence to effective treatment as well.3  
 
In order to help patients receive costly medications, patient 
assistance programs, usually sponsored by pharmaceutical 
manufacturers, state programs and/or non-profit 
organizations, have been developed to provide economic relief.  
Based on pre-specified criteria for enrollment, patient 
assistance programs can provide coupons and discounts once 
individuals join the program. Ultimately, the goal of the 
program is to prevent further clinical complications by affording 
the patient the ability to obtain needed therapy, and to  
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improve patient access to medications for little or no 
cost.4 Incorporating technology as a tool to foster adherence is 
becoming more commonplace in practice. It is predicted that 
61.9 million individuals will have a smartphone in 2021.5 The 
purpose of this report is to identify barriers of medication 
adherence and review the impact of patient assistance 
programs and technology on medication adherence. 
 
Methods 
A literature search was conducted in secondary databases, 
PubMed/MEDLINE and EBSCOhost of peer-reviewed systematic 
reviews, experimental, quasi-experimental, and observational 
reports published in English within the last fifteen years. Terms 
searched included patient assistance program, pharmacist role, 
technology, adherence or compliance, income and health. 
Investigators followed the guidelines from Peer Review of 
Electronic Search Strategies (PRESS) to conduct this review and 
the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) methodology to extract data (Figure 
1).6,7 Articles containing proposed keywords were first selected 
by the primary investigator by reviewing titles and abstracts. 
After initial review, two co-investigators further analyzed the 
selected reports. Any inconsistencies or ambiguities were 
settled through analysis with two other co-investigators until 
needed consent was reached. Using a standardized, pre-piloted 
form data were extract from the included studies to include the 
following categories: the role of the pharmacists in patient 
assistance programs, number of patients, factors that affect 
medication adherence, income and the use of technology in 
adherence and limitations. 
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Results 
A total of 697 articles were found using the searched keywords. 
Of these, ten studies met our prespecified criteria (Table 1). 
Overall, individuals with lower adherence were more 
frequently male, had several self-reported chronic diseases, 
negative expectancy of treatment, engaged in polypharmacy 
and experienced financial hardships. Education also influenced 
adherence as patients with lower education levels reported not 
understanding their current conditions or medications more 
frequently and did not feel comfortable asking a prescriber 
questions regarding their prescriptions or disease states. As 
such, education is a very important predictor for adherence as 
poor literacy leads to a low compliance with treatment, 
resulting in poor health outcomes. On the other hand, 
satisfaction with counseling was a strong positive predictor of 
adherence. When a patient is not satisfied or has not received 
quality counseling, he/she will likely not take advice given and 
will not adhere.5,13 Patient care assistance programs improved 
and was a positive predictor of medication adherence in 
patients experiencing economic issues. Similarly, adherence 
was enhanced when technology (e.g., use of a mobile 
application) was utilized to synchronize timing/remind patients 
of medication administration.1-5,8-12 Technology increases 
patient engagement, particularly with their medications, 
promote health outcomes and reduce mediation errors.5  
 
Discussion 
Our findings indicated that many barriers to medication 
adherence exist. Unfortunate consequences of medication non-
adherence include increased hospitalizations 
admissions/readmissions and healthcare costs.8 Luckily, most 
predictors of non-adherence are modifiable. For instance, 
engaging patients when making treatment decisions and 
counseling can relieve patients of any uncertainty and doubts 
surrounding their regimen and empowers individuals to take 
control of their clinical conditions while educating on the 
dangers of polypharmacy and risk of further health 
complications if non-adherence occurs. Several studies noted 
improvement of medication adherence when pharmacists are 
involved on the healthcare team to assist in these efforts. 
Pharmacists can enhance medication adherence via education 
and simplification of medication regimens through services 
such as medication therapy management. According to a report 
from the National Governors Association Center for Best 
Practices, “The critical role that medication management plays 
in treating chronic diseases suggests that the integration of 
pharmacists into chronic care delivery teams has the potential 
to improve health outcomes.”11  
 
Patient assistance programs help patients afford their 
medications, but still could be further developed to more assist 
individuals overcome other barriers of adherence. Integrating 
technology can promote patient engagement with their 
medications leading to controlled chronic conditions, less 
clinical complications and hospitalizations and lower healthcare 
costs.5 A study examining the benefits of technological support 
in the management of medication information found improved 
medication adherence and reduced medication 
errors.11 Currently, there are seven popular applications that 
are being marketed to improve medication adherence. These 
applications are: PillPack, Med Minder, Medisafe Medication 
Reminder, E-pill Once-a-day reminder, PatientPartner, 
Dosecast and My Pillbox.13 Most remind patients when to take 
medications, but do not provide the opportunity for direct 
interaction with a physician or pharmacist. Additionally, none 
give the opportunity to request medication refills. Moreover, 
the majority of the applications that are available in the market 
have a complex navigation, have small font sizes or lack task 
support.5 With this said, there is much that can be done in order 
to improve the current technology. Adding additional patient 
services, such as direct video-call with pharmacists or 
physicians, an interface that provides a user-friendly guide of 
what medications they are using, what they are for and what to 
expect, and reminder/ability to make an appointment with a 
healthcare provider would greatly enhance these technological 
resources.  
 
Conclusions 
Several barriers of medication adherence exist including 
complexity of regimen and costs of medications.  Patient 
assistance programs and technological tools, such as mobile 
applications, are necessary resources in improving medication 
adherence. Enhancements of marketed products and 
involvement of pharmacists on the healthcare team can 
promote counseling, education and improvement in 
medication adherence.    
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Figure 1. Methodology of Literature Review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Review of Literature 
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Table 1. Review of Literature 
First Author, 
Publication Year 
Study Design Sample Size (n) Findings 
Ganguli et al, 2016 Systematic review 64 Medication management and counseling in PAP 
improve care in chronic disease states with complex 
therapies and have a positive impact on adherence, 
clinical and humanistic outcomes.  
Gellad et al, 2006 Cross sectional  14,322 The doctor–patient communication is strongly 
associated with use of PAP as cost-related underuse 
of medications is common among older adults. 
Felder et al, 2016 Systematic review 33 Enrollment of a patient in PAP with additional 
medication services (e.g., counseling) was 
significantly associated with improved glycemic and 
lipid control. 
Hasting et al, 2019 Cohort study 83 A pharmacy-based referral program, the Certified 
Aging Resource Educated Specialist” (C.A.R.E.S.) 
program, affords pharmacists with the knowledge 
and means to provide long-term solutions for 
Medicare beneficiaries with limited income.  
Kletas et al, 2018 Systematic review 47 Through review of a series of recommendations 
made by various organizations that review oncology 
treatments it was found that pharmaceutical PAP for 
unfunded cancer drugs allow patients to access 
medications when provincial funding is not available. 
Hyekyung et al, 
2016 
Cross sectional 160 Medication adherence of elderly patients was 
associated with education level, health-related 
problems, dosing frequency, satisfaction with patient 
counseling, and explanation of medication, but no 
association was found with functional health literacy. 
Lassarat et al, 2006 Experimental 14,500 A novel direct-to-patient PAP program, GIPAP (Glivec 
International Patient Assistance Program, for 
imatinib use in underserved patients was 
demonstrated to be efficient and sustainable. 
Sarrafizadeh et al, 
2004 
Cohort study 44 Pharmacists helping patients enroll in 
pharmaceutical manufacturer assistance programs 
reduced patients’ expenses for prescription drugs.  
Sedlmayr et al, 
2018 
Experimental 7 A novel user-friendly interface for medication 
management received a higher system usability 
Scale score, making it more favorable to competitors 
due to its easy to use design. 
Schommer et al, 
2015 
Case series Series of reports 
published by the 
American 
Pharmacists 
Association 
As gaps exist in access to pharmacist-provided care, 
especially during transitions in care, collaborative 
practice with other healthcare providers would help 
fill these gaps but pharmacists will need to be paid 
for their services. 
PAP = Patient assistance programs  
